That is very important, because the way a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be efficient. To put it simply, we need to know how these proteins fold if we desire a drug to work. Historically, this has been a trial-and-error procedure (jeff brown prediction). And now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to develop drugs that do what they're developed to do. This was a development nearly nobody observed. However it's going to have extensive ramifications for treating illness. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be plenty of financial investment opportunities in this space, too. Shifting topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (bleeding edge). That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be surprised if it pulled back possibly considerably before going higher - jeff brown 2021 predictions. I have actually been covering bitcoin for a long period of time now. Among the very first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial suggestion, I entitled my report "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time. We were mainly informing readers. But that's not the huge concern any longer. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So think of that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. jeff brown predictions 2021. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are so lots of great private companies on the edge of hitting the general public markets And I've been working on a new way for you to invest even prior to these companies go public.
This opportunity has been developing over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to find out all the information. Go right here to book your spot for free.
Emma Walsh here, handling editor of the Journal. Routine Journal readers know that tech isn't our typical beat (jeff brown genetic sequencer stock). And when it concerns tech investing, we leave it to the professionals. Thankfully, we have several such professionals in our Rolodex. Our associate Jeff Brown will recognize to our longtime readers. He is one of the most accomplished tech investing experts we know (jeff brown genome sequencing). In truth, he had several triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the big picture and predict what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and a lot more. These patterns are experiencing rapid development and developing amazing chances for investors. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see can be found in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I've been covering for years now. jeff brown 2021 stock picks. But regardless of what numerous readers may think, this is a trend that's simply beginning. Even though the COVID-19 pandemic interfered with supply chains last year, a remarkable 250 million 5G-enabled gadgets were still offered.
And all of this ultimately led to Apple delaying the release of the 5G-enabled i, Phone 12 by two months (jeff brown latest prediction). Losing two months of manufacturing and sales actually affects the number of 5G devices are offered in the calendar year. When you consider all of that, offering 250 million units is remarkable. More importantly, the hold-ups brought on by the pandemic developed a ton of pent-up need. Which demand is now going to be pushed into 2021. In fact, I predict that more than 500 million 5G devices will be shipped in 2021 - diplomatic relations. Which's not my only 5G prediction When I've spoken about 5G in the past, I have actually explained its 3 different stages.
In Phase Two, 5G gadgets go on sale. 5G phones and other items start to reach customers. And in Phase 3, 5G services start to be used (angel investor). That's when we begin to see applications running on 5G networks. Consider things like enormous multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Stage Three by this summer. This begins something of a virtuous cycle: A lot of people do not actually care about the technology. However they will care if there are exciting applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In reality, 5G is going to open a suite of extraordinary applications: self-driving cars, the Web of Things, robotic surgical treatment, and more. All of these innovations require 5G. The financial investment chances going forward will be massive. Stepping away from 5G, the next essential technology I visualize in 2021 is CRISPR hereditary editing. CRISPR stands for "clustered regularly interspaced short palindromic repeat." It's a mouthful. However it is among the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software.
The program can crash or not work properly. CRISPR utilizes a similar idea however with our genetic code. "Typos" in our genome can cause illness. CRISPR can correct these "typos." For several years, CRISPR was mostly a specific niche technology that wasn't well understood. And during that time, there were truly just three companies running in this area. But things are altering. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're treating diseases and seeing that this technology simply works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and providing unbelievable returns. This entire industry is effectively a greenfield opportunity.
There's space for lots of business to exist in this area. jeff brown biotech stock pick for 2020. And there will be more. That's my prediction for CRISPR in 2021. I anticipate that two or three more hereditary editing business will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things happening at the convergence of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software application can accurately anticipate the folding of a protein based entirely on its amino acid series with 92. 4% accuracy. That is necessary due to the fact that the method a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be reliable.
Historically, this has actually been a trial-and-error procedure. Now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much simpler to create drugs that do what they're developed to do. And here's my next forecast. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however several drug treatments produced utilizing this innovation. This was among those developments that practically nobody observed. But it's going to have extensive ramifications for curing illness. And, of course, there will be a lot of financial investment opportunities in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be shocked if it drew back perhaps significantly before going higher. I've been covering bitcoin for a long period of time now. One of the first research reports I ever released was on bitcoin - jeff brown 1 biotech company. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anybody who followed my recommendation. However at the time of that initial recommendation, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
But no one is asking that question any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. toxic tech 5 tech darlings. Mass, Mutual is a 150-year-old institution. So think of that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more perk forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the information depends on date since February 2021, however we might not individually verify this claim. Given Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down a precise figure at this minute. Brown is best known for his sage-like ability to choose winning innovation stocks. He invested more than 25 years researching technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an outstanding point of view on the market. He's constantly on the hunt for brand-new chances, and he shares much of his best choices in the Future Report.
That's high appreciation, but it's not absurdly reasoned. Brown has an exceptional track record as a stock-picker, and he successfully anticipated a few of the most significant economic events of the previous twenty years. Although he does not appear to launch his choices to the general public, the service's success is a direct sign of Brown's stock-picking prowess. Nobody on Wall Street gets it ideal each time, but Jeff Brown's accurate predictions have actually earned him legions of devoted followers. That states a lot about his capability. The Near Future Report is released by Brownstone Research study, a prominent financial research publisher. Brownstone Research study uses a number of research study services with a wide range of specializations - diplomatic relations.
The company is likewise affiliated with Bonner & Partners, another well-respected research study publisher - jeff brown predictions 2021. On its site, Brownstone states its objective is to supply retail investors with professional-grade research: "For too long, the very best financial investment research has not been available to individual investors. It has actually been usually scheduled for financial investment banks, hedge funds, personal equity, and high-net-worth clients. jeff brown stock predictions 2021. The mission of Brownstone Research study is to make that type of proprietary research study readily available to any financiers looking to acquire an edge in the marketplaces. The objective is simple to deliver unique and lucrative investment research study discovered no place else." -Brownstone Research study website excerpt from the Jeff Brown is the creator of Brownstone Research, and he likewise acts as the firm's Chief Investment Expert.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to use its clients. After years of steady success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a household name throughout the majority of America. If you understand even a bit about the market, you understand that he has a credibility as a King Midas of sorts. jeff brown top biotech stock 2021. Whatever he touches relies on gold! Jeff is well mindful of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big project.
In truth, Brown believes S.A.V. jeff brown genetic sequencer stock. could be "the greatest pattern of the 2020s, and he's not alone. Check out these quotes from other popular S.A.V. bulls: Elon's next huge act will be marrying two innovative technologies: synthetic intelligence and electric automobiles. Musk hopes the mix will assist him establish the first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing except the vehicle market's Holy Grail. As you understand, electric automobiles and self-driving cars and truck stocks have actually been big this year, but the Wall Street machine has actually been huge on hype without much concrete result. Despite a drastic boost in competitors over the previous few years, Brown still believes Musk has the finest possibility of putting it all together.
tech could be the magic string that ties all of it together. S.A.V. means Shared Autonomous Lorry, and it might be the future of transport. Essentially, this technology would enable you to rent your vehicle as an autonomous, self-driving taxi when you're not using it. You simply leave the automobile and press a button on an app that tells the car to "join the fleet." Next thing you understand, you're unwinding on your sofa while your vehicle shuttles ride-sharers around town. Most importantly, you get to keep a substantial portion of the profits. It sounds outrageous, however it could be closed than you think.